Roche inks $1.7bn licensing agreement with Blueprint Medicines
Roche will pay $675m in upfront cash and $100m in equity investment in Blueprint Medicines, along with up…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Jul 20
Roche will pay $675m in upfront cash and $100m in equity investment in Blueprint Medicines, along with up…
25 Jun 20
The collaboration will leverage advanced StaR technology and SBDD platform to discover the advanced medicines that modulate GPCRs
24 Jun 20
Oncomine Dx Target Test identifies NSCLC in patients with human epidermal growth factor receptor 2 (HER2) mutations who…
22 Jun 20
Clover will begin phase 1 study of GSK’s Covid-19 S-Trimer vaccine (SCB-2019) in combination with GSKs pandemic adjuvant…
15 Jun 20
IVA is aimed at accelerating the supply of the vaccine and to ensure its availability to other European…
05 Jun 20
Through the agreements, AstraZeneca aims to provide global access to the vaccine, including low and middle-income countries
04 Jun 20
NVX-CoV2373 is a stable, prefusion protein designed by Novavax, leveraging its original nanoparticle technology, to work against SARS-CoV-2…
28 May 20
Thermo Fisher will leverage its drug product development, biologics manufacturing, sterile fill-finish, packaging and clinical trials logistics to…
22 May 20
Samsung Biologics is expected to provide GSK with additional capacity for large-scale manufacture of biopharmaceutical products
21 May 20
CanSinoBIO will hold rights to commercialise the vaccine product in Asia, except in Japan, while PNI will retain…